developing

Akari Therapeutics Issues 2025 End of Year Letter to Shareholders

December 30, 2025 09:15 ET  | Source: Akari Therapeutics Plc TAMPA, Fla. and LONDON, Dec. 30, 2025 (GLOBE NEWSWIRE) --…

4 weeks ago

FP Markets Celebrates 20 Years of Transforming Trading and Looks Ahead to a New Era of Growth

SYDNEY, Dec. 24, 2025 /PRNewswire/ -- Global multi-asset broker FP Markets proudly marked its twentieth anniversary this year, celebrating two decades…

1 month ago

SOS Limited Announces Development of Tier III Modular Data Center at Longfellow Ranch, Texas

NEW YORK, Dec. 22, 2025 /PRNewswire/ -- SOS Limited (NYSE: SOS) ("SOS" or the "Company") announced today that it is…

1 month ago

Kyverna Therapeutics to Report Topline Results from Registrational Phase 2 KYSA-8 Trial of KYV-101 in Stiff Person Syndrome

– Company to host live webcast and conference call Monday, December 15, 2025 at 8:00 am ET – December 14,…

1 month ago

Mercedes star shines bright as Euro NCAPs final results deliver safer options for every buyer

LEUVEN, BELGIUM – Euro NCAP’s independent assessment of the new CLA shows an outstanding safety performance with a five-star result…

2 months ago

EpiEndo Pharmaceutical’s ERJ Open Research article reports first clinical trial of glasmacinal (EP395) in COPD patients

ERJ Open Research article reports first clinical trial of glasmacinal (EP395) in COPD patients Glasmacinal, a novel macrolide, was well…

2 months ago

UroGen Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

December 05, 2025 08:00 ET  | Source: UroGen Pharma Ltd. PRINCETON, N.J., Dec. 05, 2025 (GLOBE NEWSWIRE) -- UroGen Pharma…

2 months ago

Khopoli: India’s Hottest Investment is Taking Off

MUMBAI, India, Nov. 28, 2025 /PRNewswire/ -- Positioned as a rapidly developing residential town along the Mumbai-Pune corridor, Khopoli is…

2 months ago

Genenta Reports Long-Term Survival Trends and Immune Findings in Brain Tumor (GBM) Trial

Company Announces Approximately $30 Million in Cash and Short-Term Investments Following Its October 27th Registered Direct Offering November 24, 2025…

2 months ago

Supernus Pharmaceuticals to Participate in the Piper Sandler 37th Annual Healthcare Conference

November 21, 2025 16:06 ET  | Source: Supernus Pharmaceuticals, Inc. ROCKVILLE, Md., Nov. 21, 2025 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals,…

2 months ago